A detailed history of Capital Management Associates, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Management Associates, Inc holds 4,000 shares of BMY stock, worth $236,200. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,000
Holding current value
$236,200
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$51.92 - $59.94 $207,680 - $239,760
4,000 New
4,000 $226 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Management Associates, Inc Portfolio

Follow Capital Management Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates, Inc with notifications on news.